down arrow

Q-Line Biotech

  • Market Cap: N/A
  • Industry: Healthcare Services
  • ISIN: INE1G2W01011
  • NSEID: QLINE
  • BSEID:
  • View on NSE
INR
474.60
131.6 (38.37%)
BSENSE

May 29

BSE+NSE Vol: 3673600

Access older stock analysis version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Markets Mojo
No Consolidated Results Declared by Q-Line Biotech
Half Yearly Analysis Highlights
Markets Mojo
Analysis not available
Compare Half Yearly Results Of Q-Line Biotech With
Figures in Cr
Markets Mojo
No Consolidated Results Declared by Q-Line Biotech
Half Yearly - Net Sales
Net Sales NA Cr
in

Figures in Cr
stock-summary

Half Yearly - Consolidate Net Profit
Consolidate Net Profit NA Cr
in

Figures in Cr
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) NA Cr
in

Figures in Cr
Half Yearly - Interest
Interest NA Cr
in

Figures in Cr
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) NA%
in

Figures in %
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."